ASSOCIATION OF LEPTIN LEVEL AND ERYTHROPOIESIS-STIMULATING AGENTS HYPORESPONSIVNESS IN CHRONIC HEMODIALYSIS PATIENTS

被引：0
|
作者：
Vlatkovic, Vlastimir [1 ]
Risovic, Ivona [1 ]
Popovic-Pejicic, Snjezana [1 ]
Vojvodic, Dragan [1 ]
机构：
[1] Univ Clin Ctr Republ Srpska, Banja Luka, Bosnia & Herceg
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP375
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
    Scott Sibbel
    Bradley J. Maroni
    Steven M. Brunelli
    Journal of Nephrology, 2017, 30 : 821 - 829
  • [42] Erythropoiesis-stimulating agents and thrombotic events in dialysis patients
    Suttorp, Marit M.
    Hoekstra, Tiny
    Ocak, Gurbey
    van Diepen, Anouk T. N.
    Ott, Ilka
    Mittelman, Moshe
    Rabelink, Ton J.
    Krediet, Raymond T.
    Dekker, Friedo W.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1081 - 1086
  • [43] Erythropoiesis-stimulating agents in congestive heart failure patients
    Robles Perez-Monteoliva, Nicolas Roberto
    Macias Nunez, Juan Francisco
    Perez de Villar, Julio Herrera
    MEDICINA CLINICA, 2014, 142 (05): : 215 - 218
  • [44] Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
    Hebah, Hayam
    Abdelmegied, Shaimaa
    Osman, Dina
    Khedr, Lina
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [45] Use and cost of erythropoiesis-stimulating agents in patients with cancer
    Daniel, Gregory
    Hurley, Dana
    Whyte, Joanna L.
    Willey, Vincent
    Wilson, Marcus
    Kallich, Joel
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1775 - 1784
  • [46] Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis
    Lee, Hyang Yun
    Suh, Suk-Won
    Hwang, Jin Ho
    Shin, Jungho
    FRONTIERS IN NUTRITION, 2022, 9
  • [47] Examining the Magnitude of Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients
    Weinhandl, Eric D.
    Hwang, Yunji
    Gilbertson, David T.
    Petersen, Jeffrey
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 247 - 247
  • [48] Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
    Haase, Volker H.
    Chertow, Glenn M.
    Block, Geoffrey A.
    Pergola, Pablo E.
    deGoma, Emil M.
    Khawaja, Zeeshan
    Sharma, Amit
    Maroni, Bradley J.
    McCullough, Peter A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (01) : 90 - 99
  • [49] HEPATIC ERYTHROPOIETIN SYNTHESIS IS ENHANCED IN HEMODIALYSIS PATIENTS WHO DO NOT REQUIRE ERYTHROPOIESIS-STIMULATING AGENTS
    Hirayama, Aki
    Yanagawa, Takamoto
    Kaneko, Yoko
    Nagano, Yumiko
    Owada, Shigeru
    Ishizu, Takashi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1178 - 1178
  • [50] Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients
    Duong, Uyen
    Kalantar-Zadeh, Kamyar
    Molnar, Miklos Z.
    Zaritsky, Joshua J.
    Teitelbaum, Isaac
    Kovesdy, Csaba P.
    Mehrotra, Rajnish
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (02) : 198 - 208
12345